SunOpta - Public Comps and Valuation Multiples

SunOpta Overview

About SunOpta

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Founded

1973

HQ

Employees

1.2K+

Website

sunopta.com

Sectors

Food & Beverages

Financials

LTM Revenue $749M

LTM EBITDA $92.8M

EV

$834M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

SunOpta Financials

SunOpta has a last 12-month revenue of $749M and a last 12-month EBITDA of $92.8M.

In the most recent fiscal year, SunOpta achieved revenue of $506M and an EBITDA of $36.9M.

SunOpta expects next 12-month revenue of XXX and NTM EBITDA of XXX

See SunOpta valuation multiples based on analyst estimates

SunOpta P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$441M	$506M	XXX	XXX	XXX
Gross Profit	$85.9M	$62.0M	XXX	XXX	XXX
Gross Margin	19%	12%	XXX	XXX	XXX
EBITDA	$25.8M	$36.9M	XXX	XXX	XXX
EBITDA Margin	6%	7%	XXX	XXX	XXX
Net Profit	-$3.4M	-$122M	XXX	XXX	XXX
Net Margin	-1%	-24%	XXX	XXX	XXX
Net Debt	$215M	$184M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

SunOpta Stock Performance

As of April 15, 2025, SunOpta's stock price is CAD 6 (or $4).

SunOpta has current market cap of CAD 666M (or $466M), and EV of CAD 1.2B (or $834M).

See SunOpta trading valuation data

SunOpta Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$834M	$466M	XXX	XXX	XXX	XXX	$0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

SunOpta Valuation Multiples

As of April 15, 2025, SunOpta has market cap of $466M and EV of $834M.

SunOpta's trades at 1.1x LTM EV/Revenue multiple, and 9.0x LTM EBITDA.

Analysts estimate SunOpta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for SunOpta and 10K+ public comps

SunOpta Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$834M	XXX	XXX	XXX
EV/Revenue	1.6x	XXX	XXX	XXX
EV/EBITDA	22.6x	XXX	XXX	XXX
P/E	-38.3x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	65.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get SunOpta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

SunOpta Valuation Multiples

SunOpta's NTM/LTM revenue growth is 9%

SunOpta's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $46K for the same period.

Over next 12 months, SunOpta's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate SunOpta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for SunOpta and other 10K+ public comps

SunOpta Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	15%	XXX	XXX	XXX	XXX
EBITDA Margin	7%	XXX	XXX	XXX	XXX
EBITDA Growth	43%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	16%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.4M	XXX	XXX	XXX	XXX
Opex per Employee	$46K	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	11%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry